A bill capping the level of delta-9 THC in the event voters decide to legalize adult-use marijuana moved forward by a 13-4 vote in its first House stop in the Healthcare Regulation Subcommittee.
But the bill is watered down from its original filing when it comes to flower.
After an amendment adopted in committee, Rep. Ralph Massullo’s bill (HB 1269) would limit the psychoactive compound to a 30% level in pre-rolls and whole buds, well above the 10% level in the original bill.
In processed substances, such as vapes, shatter and wax, the cap would be 60% delta-9 THC if this bill passes. For practical purposes, that likely would drive marijuana vendors to add other psychoactive isomers, including delta-8 and delta-10 THC and variants thereof, along with hexahydrocannabinol.
“We’re only at the beginning of understanding the benefits and harms of high-potency THC products,” Massullo said in introducing this bill, which he argued in his close wasn’t a “preemption” of the rights of the voters, but a sign the Legislature would “protect” the public and the medical marijuana program. Medical products wouldn’t change in this bill.
Your email address will not be published. Required fields are marked *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Comment *
Notify me of follow-up comments by email.
Notify me of new posts by email.
Δ
The industry looks back wistfully on a past year of promise but little delivery, and wonders what next under Trump For those awaiting the end of cannabis prohibition in the US, 2024…
The Oregon lawmaker has championed cannabis policy changes on Capitol Hill for nearly three decades. Half a century ago, a Republican hog farmer delivered the most convincing argument for cannabis…
As the cannabis industry continues to evolve and mature, brands must adapt their marketing strategies to stay competitive and drive growth. If you invest wisely in your marketing efforts, you’ll…
Reflecting multiple states rejection of marijuana legalization efforts and ushering in an administration seemingly hostile to cannabis, Red Wednesday revealed how uncertain regulatory policy, coupled with Herculean operational challenges, stripped…